Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

Emerging New Therapeutic Modalities

Unique Model Informed Drug Development Opportunities with PROTAC Protein Degrader

Sunday, November 10, 2024
2:35 PM – 3:00 PM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • Eric Masson, PharmD

    SVP, Early Clinical Development
    Arvinas
    Essex, Connecticut, United States

    Disclosure(s): Arvinas: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

    Handouts
Disclosure(s):
Eric Masson, PharmD: Arvinas: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)